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Unusual presentation of atrial Myxoma in a young 
Malawian male: Case report and review of literature
Case Report
Introduction
We report a 30-year-old male who presented with signs and 
symptoms of  right heart failure who was later diagnosed 
with right-sided atrial myxoma. This patient, unfortunately, 
died while waiting for cardiac surgery outside Malawi and 
postmortem was not done to ascertain the cause of  death. 
Clinical case
A 30-year-old male was admitted to Queen Elizabeth Central 
Hospital, Malawi with a two-week history of  sudden onset, 
worsening shortness of  breath on exertion and at rest with 
associated fatigue and dizziness but no syncope. This was 
followed by swelling of  the legs to the level of  the thighs but 
was without symptoms of  chest pain, orthopnea, paroxysmal 
nocturnal dyspnea, or cough. He had a 10-year history of  
drinking locally brewed spirits (kachasu) and a 12-year history 
of  smoking unfiltered tobacco (chingambwe) which could 
not be quantified objectively. There was no other relevant 
history and systemic review was unremarkable. On physical 
examination, he was afebrile, had a normal BMI of  23 Kg/
M2, was tachypneic, had a normal oxygen saturation of  99% 
on room air and was normotensive with normal and regular 
heart rate. He had mucocutaneous pallor and bilateral pitting 
oedema extending from the feet to the thighs with no sacral 
oedema, cyanosis, or lymphadenopathy. He had a raised 
Jugular Venous Pressure of  12 cm H20, had a hyperactive 
precordium with a non-displaced apex heartbeat and a right 
ventricular heave. On auscultation, he had a grade 3, non-
radiating ejection systolic murmur heard best at the left 
lower sternal edge. Abdominal examination revealed free 
fluid suggestive of  ascites but no clinical evidence of  hepatic 
or splenic enlargement. The rest of  the physical examination 
was normal. Full blood count showed normocytic anaemia 
of  10 g/dl and other parameters were normal. The following 
tests were either normal or negative: liver and renal function 
tests, serum electrolytes, HIV, hepatitis B and C and syphilis 
serology. 
A Trans-thoracic echocardiogram (TTE) showed a vascular 
right atrial mass attached to the fossa ovalis region in the 
inter-atrial septum measuring 6 cm by 4 cm with cystic core 
prolapsing in tandem with heart contraction through the 
tricuspid valve at least a third into right ventricle in diastole 
causing severe tricuspid stenosis. There was a pericardial 
effusion of  1.1 cm causing no cardiac tamponade. Aortic and 
mitral valve morphology and left ventricular ejection fraction 
(65%-75%) were normal (Figure 1). Chest radiography, 
abdominal ultrasound scan and electrocardiography were 
normal.
 
Figure 1. Four Chamber view showing right atrial myxoma 
(green arrow). (Right atrium = RA, right ventricle = RV, left 
atrium = LA and left ventricle = LV) 
Diagnosis and management
Based on the clinical findings and echocardiography a 
diagnosis of  right heart failure secondary to right atrial 
myxoma was made. Fluid overload was managed with 
intravenous furosemide (40mg) twice daily with rapid clinical 
improvement of  symptoms within three days. Unfractionated 
Subcutaneous Heparin (7500 Units) twice daily was also 
added for thromboprophylaxis. While waiting for cardiac 
surgery outside Malawi the patient’s condition deteriorated 
and he later died. 
Discussion
Primary intra-cardiac tumours occur infrequently with a 
prevalence of  0.02 % of  the general population in autopsy 
studies1. In comparison, secondary cardiac tumours are 
estimated to be 20 to 30 times more common however, 
their exact incidence is unknown 2, 3. Benign primary cardiac 
tumours are more common (75%)3 with approximately half  
being atrial myxomas and left-sided being the commonest 
(75-80%)4. They occur commonly in females (65%-70%) 
and can be seen in patients of  all age groups but the peak 
incidence is in the fourth and sixth decade of  life5-7. They 
can be multiple (5%) of  which half  are bi-atrial6, 8.  Reports 
of  atrial myxoma from Africa are scarce and the exact 
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epidemiology in Africa and Malawi is unknown.
Familial myxomas are rare (7%) and present early in life mostly 
as Carney syndrome because of  mutation of  the PRKAR1α 
gene located on the long arm of  chromosome 17 (17q22-24 
region) and transmitted in an autosomal dominant fashion9. 
Myxomas are thought of  as neoplasms of  endocardial origin 
arising from pluripotent mesenchymal cells associated with 
embryonic residues in the sub-endocardium and but they 
generally appear to grow rather quickly 10. As was with our 
case, most myxomas are seen at a narrow attachment point 
at the fossa ovalis of  the inter-atrial septum with a tendency 
to prolapse into the Mitral Apparatus 10,11. Though limited in 
the field of  view, a 2-dimensional TTE is a first-line modality 
to detect cardiac tumours. More superior but unavailable 
in our setting is the trans-oesophageal echocardiography 
(TOE) approach which can provide unimpeded visualization 
of  the atria, atrial septum, and portions of  the left and right 
ventricles and can detect small vegetation and tumours 
12. Chest radiography though normal in this patient may 
reveal right or left atrial enlargement or calcifications. 
The clinical features of  myxomas are determined by their 
location, size, and mobility. Occasionally (20%) there are no 
symptoms, particularly with small tumours but large ones 
present with one or more of  the triads of  embolism, intra-
cardiac obstruction, and constitutional symptoms 4. In Left-
sided atrial myxomas patients may present with signs and 
symptoms that mimic mitral stenosis, leading to dyspnea 
or orthopnea. If  the tumour is large enough, temporary 
complete obstruction of  the orifice of  the mitral or tricuspid 
valve may occur resulting in syncope (20%) or sudden 
death. Systemic embolism occurs in 30–40% of  patients 
with large and friable myxomas 11 and thromboprophylaxis 
was instituted in our patient in accordance. Our patient 
also presented with some constitutional disturbances, such 
as fatigue, dizziness, and laboratory abnormalities, such 
as anaemia suggesting a possible infection or the primary 
malignant disease. Sometimes myxomas can get infected 
increasing the risk of  systemic embolization. Our patient 
died while waiting for surgery outside Malawi due to a lack 
of  cardiothoracic surgery facilities in Malawi although the 
prognosis is much better after surgical resection10.
Conclusion
Atrial myxomas are very rare but should be considered in any 
patient presenting with heart failure. The diagnosis of  atrial 
myxoma can be elusive, especially when the symptoms are 
non-specific. Although easily treated in the western world, 
surgical intervention is not widely available in Malawi and 
most regions of  Africa13. We recommend an echocardiogram 
in the workup of  heart failure of  unknown aetiology to 
facilitate earlier identification of  intra-cardiac growths for 
timely intervention. The unfortunate outcome of  this case 
(patient death) highlights that young, otherwise healthy, 
Malawian patients are dying from easily treatable cardiac 
diseases because of  the lack of  cardiac surgery in Malawi.
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